A Phase 2, Prospective, Randomised, Open-Label Study of Defibrotide For The Prevention of Acute Graft-Versus-Host Disease (AGVHD) After Allogeneic Haematopoietic Cell Transplantation (HCT) Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Hudspeth, Michelle; Mori, Shahram; Nachbaur, David; Simon, Jose Antonio Perez; Stolzel, Friedrich; Riches, Marcie; Wu, Wendy; Zhang, Peixin; Amber, Vian; Yakoub-Agha, Ibrahim

Publication Date

  • June 1, 2021

webpage

published in

category

start page

  • 79

end page

  • 80

volume

  • 56

issue

  • SUPPL 1